Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Apr 27:9:113.
doi: 10.1186/1475-2875-9-113.

Field efficacy of a new mosaic long-lasting mosquito net (PermaNet 3.0) against pyrethroid-resistant malaria vectors: a multi centre study in Western and Central Africa

Vincent Corbel  1 , Joseph Chabi, Roch K Dabiré, Josiane Etang, Philippe Nwane, Olivier Pigeon, Martin Akogbeto, Jean-Marc Hougard
Affiliations
Multicenter Study

Field efficacy of a new mosaic long-lasting mosquito net (PermaNet 3.0) against pyrethroid-resistant malaria vectors: a multi centre study in Western and Central Africa

Vincent Corbel et al. Malar J. .

Abstract

Background: Due to the spread of pyrethroid-resistance in malaria vectors in Africa, new strategies and tools are urgently needed to better control malaria transmission. The aim of this study was to evaluate the performances of a new mosaic long-lasting insecticidal net (LLIN), i.e. PermaNet 3.0, against wild pyrethroid-resistant Anopheles gambiae s.l. in West and Central Africa.

Methods: A multi centre experimental hut trial was conducted in Malanville (Benin), Vallée du Kou (Burkina Faso) and Pitoa (Cameroon) to investigate the exophily, blood feeding inhibition and mortality induced by PermaNet 3.0 (i.e. a mosaic net containing piperonyl butoxide and deltamethrin on the roof) comparatively to the WHO recommended PermaNet 2.0 (unwashed and washed 20-times) and a conventionally deltamethrin-treated net (CTN).

Results: The personal protection and insecticidal activity of PermaNet 3.0 and PermaNet 2.0 were excellent (>80%) in the "pyrethroid-tolerant" area of Malanville. In the pyrethroid-resistance areas of Pitoa (metabolic resistance) and Vallée du Kou (presence of the L1014F kdr mutation), PermaNet 3.0 showed equal or better performances than PermaNet 2.0. It should be noted however that the deltamethrin content on PermaNet 3.0 was up to twice higher than that of PermaNet 2.0. Significant reduction of efficacy of both LLIN was noted after 20 washes although PermaNet 3.0 still fulfilled the WHO requirement for LLIN.

Conclusion: The use of combination nets for malaria control offers promising prospects. However, further investigations are needed to demonstrate the benefits of using PermaNet 3.0 for the control of pyrethroid resistant mosquito populations in Africa.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Experimental hut stations belonging to the Anopheles Biology & Control (ABC) network. Huts from Malanville (Northern Benin), Pitoa (Northern Cameroon), and Bobo-Dioulasso (Southern Burkina Faso) were used in this study.
Figure 2
Figure 2
Comparison of Induced Exophily obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and CTN against free flying An.gambiae s.l. in experimental huts.
Figure 3
Figure 3
Comparison of Blood Feeding Inhibition (BFI) rates obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and CTN against free flying An.gambiae s.l. in experimental huts.
Figure 4
Figure 4
Comparison of corrected mortality rates obtained for unwashed and washed PermaNet® 2.0, PermaNet® 3.0 and CTN against free flying An.gambiae s.l. in experimental huts.
See this image and copyright information in PMC

References

    1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214–217. doi: 10.1038/nature03342. - DOI - PMC - PubMed
    1. World_Health_Organization, editor. WHO. World Malaria Report. Geneva: World Health Organization; 2008. p. 215.
    1. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic reviews. 2009. pp. 1–58. - PubMed
    1. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 2008;5:e226. doi: 10.1371/journal.pmed.0050226. discussion e226. - DOI - PMC - PubMed
    1. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J. 2008;7:125. doi: 10.1186/1475-2875-7-125. - DOI - PMC - PubMed

Publication types